Breaking News, Collaborations & Alliances

Thermo Fisher to Expand Sterile Filling Capacity with New Facility in Singapore

Investment supports global health and preparedness in the Asia-Pacific region.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Thermo Fisher Scientific has unveiled plans to develop two new sterile filling lines in Singapore to extend capacity to the Asia-Pacific region for the development and manufacture of therapies and vaccines.   Established with the support of the Singapore Economic Development Board (EDB), the $130 million facility will be operated by Thermo Fisher and have the capability to manufacture pharmaceutical products to meet demand in the region and respond effectively to future health emergencies.   ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters